Article Information
History
- April 14, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Andrea Anichini1,#,
- Alessandra Molla1,
- Gabriella Nicolini1,
- Valentina E. Perotti1,
- Francesco Sgambelluri1,
- Alessia Covre2,3,
- Carolina Fazio2,
- Maria Fortunata Lofiego2,
- Anna Maria di Giacomo2,3,
- Sandra Coral2,
- Antonella Manca4,
- Maria Cristina Sini4,
- Marina Pisano4,
- Teresa Noviello5,6,
- Francesca Caruso5,6,
- Silvia Brich7,
- Giancarlo Pruneri7,8,
- Andrea Maurichi9,
- Mario Santinami9,
- Michele Ceccarelli5,6,
- Giuseppe Palmieri4,10,
- Michele Maio2,3,*,
- Roberta Mortarini1,* and
- the EPigenetic Immune-oncology Consortium AIRC (EPICA) investigators
- 1Human Tumors Immunobiology Unit, Dept. of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- 7Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- 9Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- 2Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy
- 3University of Siena, Siena, Italy
- 4Unit of Cancer Genetics, National Research Council (CNR), Sassari, Italy
- 10University of Sassari, Sassari, Italy
- 5Department of Electrical Engineering and Information Technology (DIETI), University of Naples “Federico II”, Naples, Italy
- 6BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy
- 8University of Milan, School of Medicine, Italy
- ↵#Correspondence:
Andrea Anichini, PhD, Human Tumors Immunobiology Unit, Dept. of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy. Phone+390223902817. e-mail: andrea.anichini{at}istitutotumori.mi.it.
↵* These authors contributed equally.